-
CheckOrphan NewsFlash, March 2,…
3/02/2010
CheckOrphan NewsFlash for Tuesday, March 2, 2010: breaking news about rare diseases, orphan diseases, orphan drugs, and…
-
CheckOrphan NewsFlash January 15,…
1/15/2010
CheckOrphan NewsFlash for Friday, January 15, 2010: breaking news about rare diseases, orphan diseases, orphan drugs,…
-
CheckOrphan NewsFlash January 11,…
1/11/2010
CheckOrphan NewsFlash for Monday, January 11, 2010: breaking news about rare diseases, orphan diseases, orphan drugs,…
NewsFlash
-
Brain, Blood, and Iron: Advances…
13–14 March, 2010
The overall objectives of this workshop are to: (1) define NA and NBIA…
-
Diamond Blackfan Anemia…
13–15 March, 2010
This conference is expected to generate immediate and long-term…
-
Interdisciplinary Training…
15–16 March, 2010
The goal of this meeting is to mentor the career development of a “…
-
ICORD 2010: Sixth International…
18–20 March, 2010
The VI International Conference on Rare Diseases and Orphan Drugs (ICORD…
Events
-
Mesothelioma That Killed Merlin Olsen Tough to Beat
Friday, March 12, 2010
SALT LAKE CITY -- Merlin Olsen passed away Wednesday from mesothelioma, but a doctor has given tips on how to fight the lung disease that took the U.S.U. football star's lifeWhen a tumor invades, the lungs become unable to absorb fluid in the chest cavity. The fluid build-up causes pressure in th
-
Roche Provides Update on Phase III Study of Avastin in Men With Late Stage Prostate Cancer
Friday, March 12, 2010
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the topline results of a phase III trial led by the US Cancer and Leukemia Group B (CALGB) and sponsored by the National Cancer Institute investigating the use of Avastin (bevacizumab) in combination with docetaxel chemotherapy and prednisone in T
-
Ulcerative Colitis Product Granted Reimbursement in Sweden
Friday, March 12, 2010
Ulcerative colitis (UC) is a form of inflammatory bowel disease characterized by a chronic inflammation often with ulcers in the large intestineThe symptoms of UC can differ between patients in terms of frequency and severity. The amount of the large intestine affected by UC also varies between pa
-
Stimuvax Will Become Decision Resources' Proprietary Clinical Gold Standard for the Treatment of Locally Advanced Non-Small-Cell Lung Cancer
Friday, March 12, 2010
WALTHAM, Mass. -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that Merck KGaA/Oncothyreon's Stimuvax vaccine earns Decision Resources' proprietary clinical gold standard status in 2013 and 2018 for the treatment of Avai
-
PSA Test Reduces Prostate Cancer Deaths by 40%
Friday, March 12, 2010
WASHINGTON -- When it comes to the documented 40 percent effectiveness of PSA testing in preventing death from prostate cancer, neither the American Cancer Society nor the discoverer of the PSA protein, Richard Ablin, are telling the public the complete story"The American Cancer Society is a
-
FDA Grants Orphan Drug Status to Ciprofloxacin Dry Powder Inhaler for the Treatment of Cystic Fibrosis
Thursday, March 11, 2010
Berlin -- Bayer Schering Pharma AG, Germany, announced today that an orphan drug designation has been granted by the U.S. Food and Drug Administration (FDA) for the ciprofloxacin dry powder inhaler (DPI) for the management of chronic pulmonary infections due to Pseudomonas aeruginosa in cystic A s
-
Cytokinetics Announces Orphan Drug Designation Granted to CK-2017357 for the Treatment of Amyotrophic Lateral Sclerosis
Thursday, March 11, 2010
South San Francisco, CA -- Cytokinetics, Incorporated (Nasdaq: CYTK) announced today that its fast skeletal muscle troponin activator, CK-2017357, has been granted orphan-drug designation by the U.S. Food and Drug Administration (FDA) for the potential treatment of amyotrophic lateral sclerosis (C
-
NeoPharm Announces Orphan Drug Application Filing for IL13-PE38QQR for the Treatment of Idiopathic Pulmonary Fibrosis
Thursday, March 11, 2010
LAKE BLUFF, Ill. -- NeoPharm, Inc. (Other OTC: NEOL.PK), announced today that it has filed an orphan drug application with the Office of Orphan Products Development of the United States Food and Drug Administration (FDA) to have Orphan Drug Designation granted to IL13-PE38QQR (IL13-PE) for the The
-
Scientists Identify microRNA as Possible Cause of Chemotherapy Resistance
Thursday, March 11, 2010
DEAD SEA, Jordan -- Scientists may have uncovered a mechanism for resistance to paclitaxel in ovarian cancer, microRNA-31, suggesting a possible therapeutic target for overcoming chemotherapy resistanceMohamed K. Hassan, Ph.D., a postdoctoral fellow at Hokkaido University in Japan, completed the r
-
Research Points to Way to Improve Heart Treatment
Thursday, March 11, 2010
Current drugs used to treat heart failure and arrhythmias (irregular heartbeat) have limited effectiveness and have side effectsNew basic science findings from a University of Iowa study suggest a way that treatments could potentially be refined so that they work better and target only key heart-r
